Skip to main content
. 2017 Sep 4;66(2):163–171. doi: 10.1093/cid/cix783

Figure 2.

Figure 2.

Inverse probability of treatment weighting (IPTW)–adjusted safety over time: renal failure (n = 72; restricted to patients at risk for incident renal failure, without renal failure at treatment initiation). A, Ceftazidime-avibactam group (n = 26). B, Colistin group (n = 46).